Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells - PubMed (original) (raw)
Microarray analysis reveals glucocorticoid-regulated survival genes that are associated with inhibition of apoptosis in breast epithelial cells
Wei Wu et al. Cancer Res. 2004.
Abstract
Activation of the glucocorticoid receptor (GR) results in diverse physiological effects depending on cell type. For example, glucocorticoids (GC) cause apoptosis in lymphocytes but can rescue mammary epithelial cells from growth factor withdrawal-induced death. However, the molecular mechanisms of GR-mediated survival remain poorly understood. In this study, a large-scale oligonucleotide screen of GR-regulated genes was performed. Several of the genes that were found to be induced 30 min after GR activation encode proteins that function in cell survival signaling pathways. We also demonstrate that dexamethasone pretreatment of breast cancer cell lines inhibits chemotherapy-induced apoptosis in a GR-dependent manner and is associated with the transcriptional induction of at least two genes identified in our screen, serum and GC-inducible protein kinase-1 (SGK-1) and mitogen-activated protein kinase phosphatase-1 (MKP-1). Furthermore, GC treatment alone or GC treatment followed by chemotherapy increases both SGK-1 and MKP-1 steady-state protein levels. In the absence of GC treatment, ectopic expression of SGK-1 or MKP-1 inhibits chemotherapy-induced apoptosis, suggesting a possible role for these proteins in GR-mediated survival. Moreover, specific inhibition of SGK-1 or MKP-1 induction by the introduction of SGK-1- or MKP-1-small interfering RNA reversed the anti-apoptotic effects of GC treatment. Taken together, these data suggest that GR activation in breast cancer cells regulates survival signaling through direct transactivation of genes that encode proteins that decrease susceptibility to apoptosis. Given the widespread clinical administration of dexamethasone before chemotherapy, understanding GR-induced survival mechanisms is essential for achieving optimal therapeutic responses.
Similar articles
- Glucocorticoid receptor-induced MAPK phosphatase-1 (MPK-1) expression inhibits paclitaxel-associated MAPK activation and contributes to breast cancer cell survival.
Wu W, Pew T, Zou M, Pang D, Conzen SD. Wu W, et al. J Biol Chem. 2005 Feb 11;280(6):4117-24. doi: 10.1074/jbc.M411200200. Epub 2004 Dec 7. J Biol Chem. 2005. PMID: 15590693 - Glucocorticoid receptor-mediated protection from apoptosis is associated with induction of the serine/threonine survival kinase gene, sgk-1.
Mikosz CA, Brickley DR, Sharkey MS, Moran TW, Conzen SD. Mikosz CA, et al. J Biol Chem. 2001 May 18;276(20):16649-54. doi: 10.1074/jbc.M010842200. Epub 2001 Feb 13. J Biol Chem. 2001. PMID: 11278764 - Corticosteroid inhibition of growth-related oncogene protein-alpha via mitogen-activated kinase phosphatase-1 in airway smooth muscle cells.
Issa R, Xie S, Khorasani N, Sukkar M, Adcock IM, Lee KY, Chung KF. Issa R, et al. J Immunol. 2007 Jun 1;178(11):7366-75. doi: 10.4049/jimmunol.178.11.7366. J Immunol. 2007. PMID: 17513787 - Serum Glucocorticoid-Regulated Kinase-1 in Ischemia-Reperfusion Injury: Blessing or Curse.
Mozaffari MS. Mozaffari MS. J Pharmacol Exp Ther. 2023 Dec;387(3):277-287. doi: 10.1124/jpet.123.001846. Epub 2023 Sep 28. J Pharmacol Exp Ther. 2023. PMID: 37770199 Review. - SGK-1 Signalling Pathway is a Key Factor in Cell Survival in Ischemic Injury.
Chaudhary M, Sharma V, Bedi O, Kaur A, Singh TG. Chaudhary M, et al. Curr Drug Targets. 2023;24(14):1117-1126. doi: 10.2174/0113894501239948231013072901. Curr Drug Targets. 2023. PMID: 37904552 Review.
Cited by
- Glucocorticoid receptors orchestrate a convergence of host and cellular stress signals in triple negative breast cancer.
Posani SH, Gillis NE, Lange CA. Posani SH, et al. J Steroid Biochem Mol Biol. 2024 Oct;243:106575. doi: 10.1016/j.jsbmb.2024.106575. Epub 2024 Jun 29. J Steroid Biochem Mol Biol. 2024. PMID: 38950871 Review. - Glucocorticoid Receptor (GR) Activation Is Associated with Increased cAMP/PKA Signaling in Castration-Resistant Prostate Cancer.
Bennett L, Jaiswal PK, Harkless RV, Long TM, Gao N, Vandenburg B, Selman P, Durdana I, Lastra RR, Vander Griend D, Adelaiye-Ogala R, Szmulewitz RZ, Conzen SD. Bennett L, et al. Mol Cancer Ther. 2024 Apr 2;23(4):552-563. doi: 10.1158/1535-7163.MCT-22-0479. Mol Cancer Ther. 2024. PMID: 38030378 Free PMC article. - The Potential of Hormonal Therapies for Treatment of Triple-Negative Breast Cancer.
Kirkby M, Popatia AM, Lavoie JR, Wang L. Kirkby M, et al. Cancers (Basel). 2023 Sep 24;15(19):4702. doi: 10.3390/cancers15194702. Cancers (Basel). 2023. PMID: 37835396 Free PMC article. Review. - Chronic stress-induced immune dysregulation in breast cancer: Implications of psychosocial factors.
Chen X, Wang M, Yu K, Xu S, Qiu P, Lyu Z, Zhang X, Xu Y. Chen X, et al. J Transl Int Med. 2022 Mar 5;11(3):226-233. doi: 10.2478/jtim-2021-0050. eCollection 2023 Sep. J Transl Int Med. 2022. PMID: 37662890 Free PMC article. - Prognostic Value of SGK1 and Bcl-2 in Invasive Breast Cancer.
Al-Alem U, Rauscher GH, Alem QA, Kajdacsy-Balla A, Mahmoud AM. Al-Alem U, et al. Cancers (Basel). 2023 Jun 11;15(12):3151. doi: 10.3390/cancers15123151. Cancers (Basel). 2023. PMID: 37370761 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous